GlassScriptPhysician profile
Miro Asadourian
NPI 1124587274
$1,581.50
in general payments reported to CMS, 2019-2025
9 companies · $846 in 2025
The $846 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $42.11 · 2024: $694 · 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,581.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $858.01 | 2024-2025 | Impella |
| Chiesi USA, INC. | $215.51 | 2024-2025 | Kengreal |
| Shockwave Medical, INC | $128.30 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bridgebio Pharma, INC. | $115.49 | 2025 | Attruby |
| Novartis Pharmaceuticals Corporation | $112.11 | 2024-2025 | |
| Medtronic, INC. | $68.20 | 2023-2025 | Azure Xt Dr Mri Surescan |
| Merck Sharp & Dohme LLC | $40.05 | 2023-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $28.42 | 2024-2025 | Lifevest |
| Merit Medical Systems INC | $15.41 | 2025 | Prelude Introducers |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miro Asadourian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.